Published in Leuk Res on January 01, 1981
Further evidence for T cell abnormalities in chronic lymphocytic leukaemia of the B cell type. Clin Exp Immunol (1983) 0.89
Lymphokine-activated killer cytotoxicity against leukaemic blast cells. Clin Exp Immunol (1990) 0.75
Wilms' tumor 1 mutation accumulated during therapy in acute myeloid leukemia: Biological and clinical implications. Leukemia (2006) 1.74
Increased plasma methylmalonic acid level does not predict clinical manifestations of vitamin B12 deficiency. Arch Intern Med (2001) 1.63
The effect of iron chelation on haemopoiesis in MDS patients with transfusional iron overload. Br J Haematol (1996) 1.60
Postoperative infection and natural killer cell function following blood transfusion in patients undergoing elective colorectal surgery. Br J Surg (1992) 1.59
Refractory myelomatosis treated with mitoxantrone in combination with vincristine and prednisone (NOP-regimen): a phase II study. The Nordic Myeloma Study Group (NMSG) Br J Haematol (1991) 1.45
Multiplex reverse transcription-polymerase chain reaction for simultaneous screening of 29 translocations and chromosomal aberrations in acute leukemia. Blood (1998) 1.42
[Granulocyte-macrophage colony-stimulating factor. Treatment of patients with highly malignant lymphomas and acute lymphoblastic leukemias after autologous bone marrow transplantation]. Ugeskr Laeger (1992) 1.38
Somatic MED12 mutations in uterine leiomyosarcoma and colorectal cancer. Br J Cancer (2012) 1.24
Mutational analysis of the tumour suppressor gene MMAC1/PTEN in malignant myeloid disorders. Eur J Haematol (2000) 1.22
Purification and characterization of fetal hematopoietic cells that express the common acute lymphoblastic leukemia antigen (CALLA). J Exp Med (1983) 1.16
PPD and mitogen responsiveness of lymphocytes from patients with atopic dermatitis. Clin Exp Immunol (1977) 1.08
Extensive intra- and interindividual heterogeneity of p15INK4B methylation in acute myeloid leukemia. Cancer Res (1999) 1.07
Interferon enhances the antibody-dependent cellular cytotoxicity (ADCC) of human polymorphonuclear leukocytes. J Immunol (1981) 1.04
DAP-kinase CpG island methylation in acute myeloid leukemia: methodology versus biology? Blood (2000) 0.99
Analysis of leucocyte differentiation antigens in blood and bone marrow from patients with Waldenström's macroglobulinaemia. Br J Haematol (1987) 0.99
Health technology assessment in clinical biochemistry. Methylmalonic acid: a Danish showcase. Scand J Clin Lab Invest (2003) 0.96
Purification of common acute lymphoblastic leukemia antigen positive cells from normal human bone marrow. Blood (1984) 0.96
Natural killer cell activity correlates with the amount of beta 2-microglobulin on human peripheral blood lymphocytes. Cell Immunol (1982) 0.96
[Blood transfusion increases the risk of surgical infection]. Ugeskr Laeger (1993) 0.96
A factor encoded by 7q31 suppresses expansion of the 7q- clone and delays cytogenetic progression. Cancer Genet Cytogenet (1994) 0.96
Fate of tumor cells injected into left ventricle of heart in BALB/c mice: role of natural killer cells. J Natl Cancer Inst (1988) 0.95
Cleaved intracellular plasminogen activator inhibitor 2 in human myeloleukaemia cells is a marker of apoptosis. Br J Cancer (1994) 0.95
Vitamin B-12 treatment has limited effect on health-related quality of life among individuals with elevated plasma methylmalonic acid: a randomized placebo-controlled study. J Intern Med (2003) 0.94
Desferrioxamine treatment reduces blood transfusion requirements in patients with myelodysplastic syndrome. Br J Haematol (1992) 0.91
Natural killer (NK)-cell activity and antibody-dependent cellular cytotoxicity (ADCC) in primary preleukemic syndrome. Leuk Res (1984) 0.91
Restoration of defective cellular immunity by levamisole in a patient with immunoblastic lymphadenopathy. Scand J Haematol (1976) 0.90
Presence of clone-specific markers at birth in children with acute lymphoblastic leukaemia. Br J Cancer (2002) 0.89
Orderly expression of B cell antigens during the in vitro differentiation of nonmalignant human pre-B cells. J Immunol (1985) 0.89
An improved technique for obtaining E rosettes with human lymphocytes and its use for B cell purification. J Immunol Methods (1976) 0.89
Antibody response to pneumococcal vaccine in splenectomized adults and adolescents. Acta Pathol Microbiol Immunol Scand C (1982) 0.89
Kinetics of BCR-ABL fusion transcript levels in chronic myeloid leukemia patients treated with STI571 measured by quantitative real-time polymerase chain reaction. Eur J Haematol (2002) 0.88
[Extramedullary manifestations among adult patients with acute lymphoblastic leukemia (ALL)]. Ugeskr Laeger (1991) 0.88
Rapid and sensitive minimal residual disease detection in acute leukemia by quantitative real-time RT-PCR exemplified by t(12;21) TEL-AML1 fusion transcript. Genes Chromosomes Cancer (1999) 0.88
Endogenous and adoptively transferred A-NK and T-LAK cells continuously accumulate within murine metastases up to 48 h after inoculation. In Vivo (1999) 0.87
Bcl-xL anti-apoptotic network is dispensable for development and maintenance of CML but is required for disease progression where it represents a new therapeutic target. Leukemia (2013) 0.87
Vitamin B12 treatment normalizes metabolic markers but has limited clinical effect: a randomized placebo-controlled study. Clin Chem (2001) 0.87
The cellular immune response after splenectomy in humans. Impaired immunoglobulin synthesis in vitro. Scand J Haematol (1983) 0.86
Two small lymphocyte subpopulations in human peripheral blood. I. Purification and surface marker profiles. Int Arch Allergy Appl Immunol (1978) 0.86
13-cis retinoic acid treatment of myelodysplastic syndromes. Leuk Res (1987) 0.86
In vitro parameters of cell-mediated immune reactions in healthy individuals following immune-stimulation attempts with levamisole. Acta Allergol (1975) 0.86
ATP-ase activity of purified human normal T- and B-lymphocytes. Scand J Haematol (1978) 0.85
Breast tumour as a first manifestation of extramedullary relapse in acute lymphoblastic leukaemia. Scand J Haematol (1984) 0.84
Identification and cloning of a prethymic precursor T lymphocyte from a population of common acute lymphoblastic leukemia antigen (CALLA)-positive fetal bone marrow cells. J Exp Med (1987) 0.84
Optimization of a flow cytometric method for the simultaneous measurement of cell surface antigen, DNA content, and in vitro BrdUrd incorporation into normal and malignant hematopoietic cells. Cytometry (1998) 0.84
Expression of TEL-AML1 fusion transcripts and response to induction therapy in standard risk acute lymphoblastic leukemia. Leuk Lymphoma (2001) 0.83
Analysis of leukocyte differentiation antigens in blood and bone marrow from preleukemia (refractory anemia) patients using monoclonal antibodies. Blood (1986) 0.83
Herpes simplex virus and intraoral ulcers in immunocompromised patients with haematologic malignancies. Eur J Clin Microbiol Infect Dis (1990) 0.83
A two-color flow cytometry assay for detection of hairy cells using monoclonal antibodies. Blood (1987) 0.83
Serum beta 2-microglobulin in acute and chronic leukaemia. Scand J Haematol (1980) 0.83
Isolated gingival relapse in acute myeloid leukaemia. Eur J Haematol (1988) 0.82
Characterization of t(12;21) breakpoint junctions in acute lymphoblastic leukemia. Leukemia (2001) 0.82
Evaluation of transfusional iron overload before and during iron chelation by magnetic resonance imaging of the liver and determination of serum ferritin in adult non-thalassaemic patients. Br J Haematol (1995) 0.82
Gingival status during chemical plaque control with or without prior mechanical plaque removal in patients with acute myeloid leukaemia. J Clin Periodontol (1992) 0.82
Optimization of a method for simultaneous analysis of cell surface phenotype and cell cycle in human bone marrow and peripheral blood leukocytes by flow cytometry: the value of both internal and external standards. Anal Cell Pathol (1993) 0.82
Comparison between 125IUdR and 51Cr as cell labels in investigations of tumor cell migration. Int J Rad Appl Instrum B (1990) 0.82
Monocyte cytotoxicity after splenectomy. Scand J Haematol (1981) 0.81
A quantitative evaluation of erythropoiesis in myelodysplastic syndromes using multiparameter flow cytometry. Leuk Res (1993) 0.81
Non-invasive assessment of tissue iron overload in the liver by magnetic resonance imaging. Br J Haematol (1994) 0.81
Detection of splenosis and ectopic spleens with 99mTc-labelled heat damaged autologous erythrocytes in 90 splenectomized patients. Scand J Haematol (1981) 0.81
Immunoglobulin classes and persistence of anti-pneumococcal antibodies in splenectomized adults and adolescents after pneumococcal vaccination. Acta Pathol Microbiol Immunol Scand C (1983) 0.80
Complement studies in splenectomized patients. Scand J Haematol (1983) 0.80
Enumeration of organ-associated natural killer cells in mice: application of a new stereological method. APMIS (1992) 0.80
Heart transplantation in a case of juvenile hereditary haemochromatosis followed up by MRI and endomyocardial biopsies. Eur J Haematol (1993) 0.80
Indirect evidence for the potential ability of magnetic resonance imaging to evaluate the myocardial iron content in patients with transfusional iron overload. MAGMA (2001) 0.79
The effect of iron overload and iron reductive treatment on the serum concentration of carbohydrate-deficient transferrin. Br J Haematol (1994) 0.79
Detection of mutations in GC-rich DNA by bisulphite denaturing gradient gel electrophoresis. Nucleic Acids Res (1998) 0.79
Malignant monoblasts can function as effector cells in natural killer cell and antibody-dependent cellular cytotoxicity assays. Blood (1981) 0.79
Natural killer function following allogeneic bone marrow transplantation. Very early reemergence but strong dependence of cytomegalovirus infection. Transplantation (1988) 0.79
Failure of pneumococcal vaccination in a splenectomized child. Acta Paediatr Scand (1982) 0.79
Transfer factor in mycosis fungoides: three years experience. Dermatologica (1980) 0.79
Acute myeloid and lymphoblastic leukemia in adults. The course of the disease in 315 patients from one region, during a ten-year period. Dan Med Bull (1989) 0.79
Effect of recombinant alpha interferon on NK and ADCC function in lung cancer patients: results from a phase II trial. J Interferon Res (1984) 0.79
The use of monoclonal antibodies in clinical haematology--the art of limitation. Scand J Haematol (1984) 0.78
Aclarubicin in the treatment of acute nonlymphocytic leukemia refractory to treatment with daunorubicin and cytarabine: a phase II trial. Cancer Treat Rep (1984) 0.78
Interferon-induced augmentation of cytotoxic killer cell generation in mixed lymphocyte cultures: analysis of the effector cell product. Scand J Immunol (1981) 0.78
Neutrophil chemotaxis and phagocytosis in juvenile periodontitis. J Periodontal Res (1984) 0.78
ATP-ase activity of lymphocytes from normal individuals and patients with cancer. Cancer (1972) 0.78
Effect of plaque removal on patients with acute leukemia. J Oral Pathol Med (1989) 0.78
Selective effects of alpha interferon on human T-lymphocyte subsets during mixed lymphocyte cultures. Scand J Immunol (1983) 0.78
Potentially pathogenic microorganisms in the oral cavity during febrile episodes in immunocompromised patients with haematologic malignancies. Scand J Infect Dis (1989) 0.78
Lymphocyte transformation, IgE and T-cells in eczema vaccinatum treated with transfer factor. A case report. Acta Derm Venereol (1975) 0.78
HIV infection in acute myeloblastic leukemia: a similar case. Am J Clin Pathol (1987) 0.78
Relation of blast cell survival and proliferation to chemotherapy resistance in AML. Br J Haematol (1996) 0.78
Validation and clinical implication of a quantitative real-time PCR determination of MDR1 gene expression: comparison with semi-quantitative PCR in 101 patients with acute myeloid leukemia. Eur J Haematol (2003) 0.78
Development of standardized approaches to reporting of minimal residual disease data using a reporting software package designed within the European LeukemiaNet. Leukemia (2011) 0.78